Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1300-1306

  Guo, Lian ^a   Yue, Xu ^a   Xianxiang, Zhang ^a   Yong, Luo ^a   Weijuan, Liu ^a   Bing, Chen ^b  

^a CHONGQING THREE GORGES UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Continuous subcutaneous insulin infusion; Insulinization; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; RECOMBINANT HUMAN INSULIN;

ADULT; AGED; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PERIPHERAL NEUROPATHY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84884731820     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1300     Document Type: Article

References (34)

1. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, et al: Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328: 697-702, 1993.
2. Defronzo RA: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795, 2009.
3. Stumvoll M, Goldstein BJ and van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346, 2005.
4. Kahn SE, Hull RL and Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846, 2006.
5. Green A, Christian Hirsch N and Pramming SK: The changing world demography of type 2 diabetes. Diabetes Metab Res Rev 19: 3-7, 2003.
6. Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH and Lau J: Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev 2: CD004095, 2005.
7. Ripsin CM, Kang H and Urban RJ: Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician 79: 29-36, 2009.
8. Edelman SV, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X and Frias JP: Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther 12: 627-633, 2010.
9. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R and Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 31: 173-175, 2008.
10. Brunton S: Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 121 (Suppl): S35-S41, 2008.
11. Pickup J, Mattock M and Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324: 705, 2002.
12. Pickup JC and Sutton AJ: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 25: 765-774, 2008.
13. Bode BW, Steed RD and Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 19: 324-327, 1996.
14. Leiter LA; The Diabetes Control and Complications Trial Research Group: Use of bioelectrical impedance analysis measurements in patients with diabetes. Am J Clin Nutr 64 (Suppl): 515S-518S, 1996.
15. Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB and Raskin P: A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28: 1568-1573, 2005.
16. Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS and Morgan NA; Department of Veterans Affairs Implantable Insulin Pump Study Group: Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. JAMA 276: 1322-1327, 1996.
17. Valensi P, Moura I, Le Magoarou M, Pariès J, Perret G and Attali JR: Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabetes Metab 23: 51-57, 1997.
18. De Vries JH, Snoek FJ, Kostense PJ, Masurel N and Heine RJ; Dutch Insulin Pump Study Group: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25: 2074-2080, 2002.
19. Hanaire-Broutin H, Melki V, Bessières-Lacombe S and Tauber JP; The Study Group for the Development of Pump Therapy in Diabetes: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 23: 1232-1235, 2000.
20. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR and Reinhardt RR: Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26: 2598-2603, 2003.
21. García-García E, Galera R, Aguilera P, Cara G and Bonillo A: Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injections of glargine in pediatric patients. J Pediatr Endocrinol Metab 20: 37-40, 2007.
22. Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ and Qin GM: Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern Med 50: 1569-1574, 2011.
23. Gorden P, Hendricks CM and Roth J: Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states. Diabetologia 10: 469-474, 1974.
24. Larsen ML, Hørder M and Mogensen EF: Effect of l -term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 323: 1021-1025, 1990.
25. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R and Zinman B; American Diabetes Association; European Association for Study of Diabetes: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32: 193-203, 2009.
26. Ceriello A: Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54: 1-7, 2005.
27. Hirsch IB and Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 19: 178-181, 2005.
28. Cryer PE: The barrier of hypoglycemia in diabetes. Diabetes 57: 3169-3176, 2008.
29. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG and Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559, 2008.
30. Zammitt NN and Frier BM: Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 28: 2948-2961, 2005.
31. Zhang L, Gianani R, Nakayama M, Liu E, Kobayashi M, Baschal E, Yu L, Babu S, Dawson A, Johnson K, Jahromi M, Aly T, Fain P, Barker J, Rewers M and Eisenbarth GS: Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp 292: 85-98, 2008.
32. Ligthelm R and Davidson J: Initiating insulin in primary care - the role of modern premixed formulations. Prim Care Diabetes 2: 9-16, 2008.
33. Zinman B: Initial combination therapy for type 2 diabetes mellitus: is it ready for prime time? Am J Med 124 (Suppl): S19-S34, 2011.
34. Ye RG and Lu ZY (eds): Organophosphorus intoxication In: Department of Internal Medicine. 6th edition. People's Medical Publishing House, Beijing, China, pp 961-967, 2003.